Former NHS Supply Chain Value-Based Procurement Lead and UK Government GEP Dealmaker Join Forces in China: How Can MedTech Companies Conquer Overseas Markets?

       Currently, the global landscape of the pharmaceutical and medical device industry is undergoing accelerated restructuring, with regulatory requirements in overseas markets continuing to tighten. International market expansion has shifted from simple product exports to a systematic competition driven by the synergistic advancement of regulatory compliance, clinical evidence generation, channel partnerships, local operations, procurement market access, and capital linkages. For Chinese pharmaceutical and medical device companies seeking to establish a presence in overseas markets, understanding target market regulations, building local resource networks, and enhancing execution capabilities for international expansion have become critical issues in their globalization journey.

To help Chinese pharmaceutical and medical device enterprises furtherUnderstand overseas market regulations, leverage international resources, and enhance the efficiency of global market expansion, GMPC, in collaboration with the UK Department for Business and Trade, GHWP (China) Academy, and VCBeat, willTo be held in Guangzhou on June 17, 2026GMPC – Pharmaceutical and Medical Device International Market Expansion Forum · Guangzhou Station，Focusing on the key issues in the international market expansion of pharmaceutical and medical device enterprises, helping companies move from market assessment to actual implementation.

This forum will inviteUK Government’s Global Entrepreneur Programme (GEP) Dealmaker Dace Dimza-JonesandBrian Mangan, Founder and CEO of Luach Consulting Group and Former Head of Value-Based Procurement at NHS Supply ChainOn-site sharing.

Dace Dimza-Jones will focus onOverview of the UK Life Sciences Market, introducing the UK's life sciences industry environment and innovation ecosystem,Corporate Entry Pathways and Resource Matchmaking Opportunities, helping enterprises understand industrial opportunities and international growth pathways in the UK market.

Brian Mangan will focus on interpretingNHS Procurement System: A Guide for MedTech Companies, analyzing the key considerations for medical technology products entering the UK healthcare systemProcurement Mechanisms, Supplier Access Criteria, and Commercial Implementation Pathways, providing a practical perspective for enterprises to understand the NHS procurement system.

ForPharmaceutical and Medical Device Companies Seeking to Enter the UK and European Marketsthe insights shared by the two experts will help companies gain a clearer understanding of market entry barriers, procurement logic, and resource-linking strategies in mature markets.

In addition, this forum will also inviteKuang Yudi, Director of the Development and Operations Center, Guangdong Research Institute of Novel Biomaterials and High-End Medical DevicesAttending, he will focus onGlobal Harmonization of Medical Device Regulations and Capacity BuildingThis session provides professional insights to help enterprises enhance their overseas market expansion capabilities, covering international regulatory harmonization for medical devices, understanding of market access requirements, compliance capacity building, and market entry preparation.

Meanwhile, the forum will also inviteMGI Tech, Dymind Biotechnology, Lepu Cloud Intelligence, Mediplus Technology, Northcore Life Sciences, and other enterprises, andRepresentatives from the organization participated in the exchange, drawing on their practical experience in global expansion and industry services to jointly discuss key issues faced by pharmaceutical and medical device companies in market selection, resource establishment, regulatory compliance, and commercialization.

This forum not only focuses on trend analysis but also emphasizes practical exchange. The practical dialogue session will center on the core pain points in the internationalization of pharmaceuticals and medical devices, including breaking through overseas branding and channel barriers, market selection from scratch, commercialization after certification, and building market access and organizational capabilities.

Compared to one-way information sharing, practical dialogues place greater emphasis on the exchange and interplay of corporate experience, resource providers’ assessments, and industrial service capabilities. This approach helps participating companies understand global expansion pathways from diverse perspectives, minimize inefficient trial-and-error, and enhance the efficiency of resource matchmaking.

Corporate Market Expansion, Overseas Channels, and Business Cooperation Team

Head of Registration Compliance, Clinical Access, and Regulatory Affairs

Head of the Department for Corporate Strategic Development, Investment & Financing, and International Cooperation

Representatives of Investment Institutions Focusing on the Overseas Expansion of Pharmaceuticals and Medical Devices

Regulatory consulting, channel services, cross-border finance, brand communication, and other industrial service agencies

Overseas Resource Providers, Channel Partners, and Partner Institutions

Conference Registration:Please scan the QR code on the poster below to complete your registration.

Conference Inquiries, Business Cooperation:Ms. Wang 17774983530 (WeChat ID same)

   See you in Guangzhou on June 17!

GMPC Pharmaceutical and Medical Device International Market Expansion Series of Activities Held During the 2026 Top 100 ConferenceInternational Market Expansion Forum for Pharmaceuticals and Medical Devices · Shanghai Stop, focusing on core issues such as the global expansion of pharmaceuticals and medical devices, market access, channel partnerships, and international resource linkage, to continuously support Chinese pharmaceutical and medical device companies in expanding into the global market.

Meeting Link:https://www.vbdata.cn/1519071013